HomeBusinessBharat Biotech partners with Precisa Medicamentos to supply Covaxin in Brazil

Bharat Biotech partners with Precisa Medicamentos to supply Covaxin in Brazil

Date:

Trending

- Advertisement -
Advertise During Budget
Advertise During Budget
Advertise During Budget
Advertise During Budget

India based pharmaceutical company Bharat Biotech has signed an agreement with Precisa Medicamentos to supply coronavirus vaccine Covaxin to Brazil.

In a statement issued, the company said, “It is understood between both parties that supplies of Covaxin will be prioritized for the public market through a direct procurement by the Government of Brazil.”

- Advertisement -

“The supplies to the private market would be based upon received of market authorization from ANVISA – the Brazilian regulatory authority,” the statement said.

Speaking on the deal, Bharat Biotech Chairman and Managing Director Dr. Krishna Ella said: “Our goal for all vaccines developed at Bharat Biotech is to provide global access to populations that need it the most. We are happy to note that vaccines innovated in India can address the public health needs of Brazil.”

THE SNAPSHOTS, IN YOUR INBOX

Get quick snaps of everyday happening, directly in your inbox.

We don’t spam! Read our privacy policy for more info.

- Advertisement -
Krishna Mali
Krishna Mali
Founder, CEO & Group Editor of TechGraph.
spot_img

More Latest Stories

Related Stories